Literature DB >> 3549939

Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.

T D Rao, P R Rao.   

Abstract

Cell-mediated immune (CMI) responses were measured in 39 lepromatous, 44 erythema nodosum leprosum (ENL), and 22 post-ENL patients. The leukocyte migration inhibition test was used to measure CMI responses to mitogen phytohemagglutinin-P (PHA), crossreacting antigen purified protein derivative (PPD) of tuberculin, and armadillo-derived whole and sonicate Mycobacterium leprae. "Early T" lymphocytes of the peripheral blood were also enumerated using the rosetting technique. Significantly enhanced immune responses (lower migratory indices) were found to whole M. leprae during ENL. Although responses were high with PHA and PPD, they were identical in all of the groups, indicating that during ENL reaction M. leprae-specific responses are enhanced. "Early T" lymphocytes also showed a significant increase in ENL reactions compared to lepromatous patients. However, there was no response to the leprolin skin test in ENL patients in contrast to the enhanced in vitro CMI responses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549939

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  6 in total

1.  A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.

Authors:  E Filley; A Andreoli; J Steele; M Waters; D Wagner; D Nelson; K Tung; T Rademacher; R Dwek; G A Rook
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

2.  Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.

Authors:  E N Sarno; G E Grau; L M Vieira; J A Nery
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

3.  Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease.

Authors:  T C Peterson
Journal:  Can J Infect Dis       Date:  1995-01

4.  Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.

Authors:  E P Sampaio; A L Moreira; E N Sarno; A M Malta; G Kaplan
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

5.  Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.

Authors:  Edessa Negera; Stephen L Walker; Yonas Bekele; Hazel M Dockrell; Diana N Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2017-12-18

Review 6.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.